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Abstract
The marginal zone macrophages of the spleen are implicated in the clearance of polysaccharides,
but underlying mechanisms need to be pinpointed. SIGN-R1 is one of ®ve recently identi®ed
mouse genes that are homologous to human DC-SIGN and encode a single, external, C-terminal C-
type lectin domain. We ®nd that a polyclonal antibody to a speci®c SIGN-R1 peptide reacts
primarily and strongly with a subset of macrophages in the marginal zone of spleen and lymph
node medulla. In both sites, SIGN-R1 exists primarily in an aggregated form, resistant to
dissociation into monomers upon boiling in SDS under reducing conditions. Upon transfection into
three different cell lines, high-mol.-wt forms bearing SIGN-R1 are expressed, as well as reactivity
with ER-TR9, a mAb previously described to react selectively with marginal zone macrophages.
SIGN-R1-expressing macrophages preferentially sequester dextrans following i.v. injection.
Likewise, when phagocytic cells are enriched from spleen and tested in culture, dextran is
selectively endocytosed by a subset of very large SIGN-R1+ cells representing ~5% of total
released macrophages. Uptake of FITC±dextran by these macrophages in vivo and in vitro is
blocked by ER-TR9 and polyclonal anti-SIGN-R1 antibodies. Following transfection with SIGN-R1,
cell lines become competent to endocytose dextrans. The dextran localizes primarily to
compartments lacking transferrin receptor and the LAMP-1 CD107a panlysosomal antigen.
Therefore, SIGN-R1 mediates the uptake of dextran polysaccharides, and it is predominantly
expressed in the macrophages of the splenic marginal zone and lymph node medulla.
Introduction
The marginal zone of the spleen [reviewed in (1)] is an
anatomical region that surrounds each white pulp nodule,
separating the lymphocyte-rich white pulp from the vascular
and macrophage-rich red pulp. It is comprised of distinctive
B cells (2,3) and macrophages (1). The IgM+ marginal zone
B cells are distinguished from the more abundant B cells in the
follicles of splenic white pulp and other peripheral lymphoid
organs by a lack of Igd and CD23 (a C-type lectin that can act
as a low-af®nity Fce receptor), but high levels of CD21 (a
receptor for the C3d complement fragment) and CD1d (which
presents glycolipids to NKT cells). Marginal zone B cells can
produce antibody to polysaccharides (2,4), a function that has
been solidi®ed by new experiments with mice selectively
depleted of this B cell subset (5). The marginal zone
macrophages also have distinctive properties. They react
selectively with a mAb called ER-TR9 (6,7), which does not
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react with macrophages in other regions of the spleen, such as
CD169+ marginal metallophils and F4/80+ red pulp macro-
phages. Marginal zone macrophages avidly internalize poly-
saccharides like dextran, Ficoll and hydroxyethylated starch
(7±10), although the consequences of this uptake remain to be
pinpointed.
In a separate line of research on the mechanism whereby
dendritic cells (DC) initiate immune responses from resting T
lymphocytes, Geijtenbeek et al. identi®ed a new DC-
restricted, C-type lectin that binds to an Ig superfamily
adhesion molecule, ICAM-3/CD50, expressed on resting T
cells (11). The lectin was named DC-SIGN, for DC-Speci®c
ICAM-3 Grabbing Non-Integrin, to emphasize the fact that this
new lectin was distinct from the integrins that had been
pinpointed previously as ligands for the ICAM family. Upon
cloning, DC-SIGN proved to be identical to a previously
de®ned gene expressed in placenta and capable of binding
the HIV-1 envelope glycoprotein (12). Geijtenbeek et al. (13)
then demonstrated that DC-SIGN was responsible in large
part for the capacity of DC to bind HIV-1 and transmit the virus
to T cells, where it then replicates vigorously (14,15). The
function of DC-SIGN in HIV-1 sequestration and transmission
requires its cytosolic domain (16), which contains three
different motifs for endocytic uptake and intracellular traf®c
(16,17). In a series of recent developments, it has been shown
the DC-SIGN is also involved in the binding of several other
infectious agents including at this time the Ebola virus
(18), human cytomegalovirus (19), Leishmania major (20)
and Mycobacterium tuberculosis (21,22).
To better understand DC-SIGN function in vivo, we decided
to identify the mouse homologue. To our surprise, the
experiments revealed an additional family of four closely
linked homologous genes, termed SIGN-R1, 2, 3 and 4, yet
none of these were detectably expressed in several popula-
tions of mouse DC (23). We therefore wanted to identify the
cellular sites of expression and function of the new SIGN-R,
beginning here with SIGN-R1. We will show that SIGN-R1 is
expressed at high levels in the spleen and lymph node, but
this expression is con®ned to a subset of macrophages in the
splenic marginal zone and lymph node medulla. The lectin
proves to be responsible for the uptake of polysaccharides
in vivo in the marginal zone and in vitro in selected populations
of splenic macrophages. Another laboratory, working
independently, has also reported similar ®ndings (24).
Methods
Mice and cell culture
C57BL/6 mice were purchased from Taconic (Germantown,
NY) and Japan SLC (Hamamatsu, Shizuoka, Japan). Mice of
both sexes were kept under speci®c pathogen-free conditions
until use at 6±10 weeks of age. All experiments were
conducted according to institutional guidelines. 293 human
renal epithelial cells, CHO cells, and RAW264.7 and P388D1
mouse macrophage cell lines (ATCC, Manassas, VA) were
cultured in DMEM with 10% FCS, 100 U/ml penicillin G and
100 mg/ml streptomycin. Two other mouse macrophage cell
lines, J774.1 and IC-21 cells, were cultured in RPMI 1640 with
10% FCS and antibiotics.
Antibodies and microscopy
Rabbit polyclonal antibodies against the C-terminal 13-amino-
acid peptide of SIGN-R1 (amino acid sequence: N-
WICKKSATPCTEG-C) were raised and puri®ed with a pep-
tide-af®nity column by ResGen/Invitrogen (Huntsville, AL).
Anti-CD169 (SER-4) and F4/80 antibodies to antigens abun-
dant on macrophages were puri®ed from supernatants of the
SER-4 and F4/80 hybridomas, kind gifts of Dr Siamon Gordon
(Oxford University, Oxford, UK). Anti-MHC class II b chain
antibody was puri®ed from supernatants of the KL295
hybridoma (ATCC). Anti-human DC-SIGN antibody was pro-
vided by Dr Thomas Moran (Mount Sinai School of Medicine,
New York, NY). Antibodies to the following targets were
purchased: green ¯uorescent protein (GFP; BD Biosciences
Clontech, Palo Alto, CA), actin (Research Diagnostics,
Flanders, NJ), marginal zone macrophages (ER-TR9; BMA
Biomedicals, Augst, Switzerland), macrophages (MARCO;
Serotec, Raleigh, NC), DC (CD11c; BD Biosciences
PharMingen, Palo Alto, CA) and B cells (B220, BD
Biosciences PharMingen). A deconvolution microscope
(Olympus America, Melville, NY), and one-, two- or three-
color ¯uorescence labeling was used to visualize subsets of
leukocytes as well as endocytosed polysaccharides in 1-mm
sections through lymphoid tissues, primary macrophages,
and various cell lines and their transfectants. The identity and
colors of the ¯uorescent reagents are listed in the micro-
graphs.
Vector construction and transient expression
A eukaryotic expression vector encoding the open reading
frame (ORF) of GFP, pEGFP-N1 (BD Biosciences), was modi-
®ed to make fusion proteins between GFP and the C-type lectin
domains of mouse DC-SIGN, human DC-SIGN and mouse
SIGN-R1. In brief, the termination codon in the ORF of GFP was
removed and then the ORF of GFP cDNA was ligated in-frame
with that of each C-type lectin domain. To express SIGN-R1
without a cytosolic domain, a fragment of SIGN-R1 cDNA
encoding the ®rst 47 amino acids was deleted. Then an initiation
ATG codon was inserted before the codon corresponding to
amino acid 48 of the SIGN-R1 protein and the mutant named
SIGN-R1#48. Expression vectors containing the ORF of various
GFP±C-type lectin fusion proteins, as well as a full-length and a
deletion mutant of SIGN-R1 cDNA were transfected into 293,
CHO and RAW 264.7 cells with Lipofectamine 2000 reagent
(Invitrogen, Carlsbad, CA). Two days after transfection, cells
were harvested and lysed for analysis.
SDS±PAGE and Western blot analysis
Cells were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris±
HCl, pH 8.0, 1% Nonidet P-40, 0.5% sodium deoxycholate and
0.1% SDS) supplemented with protease inhibitor cocktails
(Sigma-Aldrich, St Louis, MO) and stored at ±80°C. Each lysed
sample, equivalent to 1±2 3 105 cells, was mixed with an equal
volume of 2 3 SDS sample buffer with/without b-mercap-
toethanol (b-ME) and boiled at 95°C for 5 min. Then, the
samples of lysate were separated in 8, 10, 12 or 4±15%
gradient SDS±PAGE and transferred onto PVDF membranes,
followed by incubation with antibodies. Antibody-reactive
bands on the blots were visualized by incubation with
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peroxidase-labeled secondary antibodies followed by treat-
ment with ECL Plus chemiluminescent substrate (Amersham
Pharmacia Biotech, Piscataway, NJ) and exposure in Kodak
BioMax Light ®lm (Eastman Kodak, Rochester, NY).
Polysaccharides
FITC±anionic dextran and Texas Red±dextran (mol. wt 70 kDa;
Molecular Probes, Eugene, OR) and FITC±dextran (mol. wt
2000 kDa; Sigma-Aldrich) were purchased. To study endocy-
tosis of these polysaccharides in vivo, 100 mg/mouse was
administered by the i.v. route and uptake studied from 1 to 48 h
later; alternatively, the polysaccharides were added in vitro at
10 mg/ml for 2±12 h on ice or at 37°C to cultured macrophages
from spleen and to cell lines transfected with SIGN-R1 or empty
vector as negative control. To test inhibition of uptake with anti-
SIGN-R1 antibodies, we used doses of 25 mg antibody per
animal given i.v. prior to 100 mg of dextran, or 10 mg/ml antibody
in vitro during the administration of 2 mg/ml dextran, with non-
reactive rat and rabbit Ig serving as negative controls.
Isolation and enrichment of marginal zone macrophages
from mouse spleen
Paramagnetic particles with or without a ¯uorescent label (1±2
mm, 2.73% solution, cat. no. 19133; Polysciences, Warrington,
PA) were washed 5 times with PBS and 0.2 ml of the 0.273%
solution was injected i.v. After 4 h, spleens were digested with
collagenase as described previously (25) and the single
suspension was depleted of erythrocytes by hemolysis. The
cells were suspended in RPMI 1640 supplemented with 5%
FCS and antibiotics (R5 medium) at 3 3 107/ml, and passed
through nylon mesh. The cells phagocytosing parmagnetic
particles were collected on a magnetic apparatus (Dynal, Oslo,
Norway), suspended in 5 ml of R5 medium and further enriched
by a second round of magnetic beading. The isolated cells
were suspended in R5 and seeded onto poly-L-lysine-coated
coverslips placed in 24-well plates at 4 3 104 cells/600 ml. One
hour after incubation in a CO2 incubator, the cells were ®xed
with 3% paraformaldehyde in PBS for 20 min at room tempera-
ture, washed 3 times with PBS, and then permeabilized for 15
min at room temperature with 0.05% saponin in RPMI 1640
supplemented with 10% FCS and 10 mM HEPES at pH 7.4. To
identify SIGN-R1+ macrophages, the cells were ®rst incubated
with 2.4G2 mAb (anti-CD16/32) supernatant at 1/5 dilution for 2
h and then stained with 7.5 mg/ml SIGN-R1 or control rabbit IgG
followed by biotinylated F(ab¢)2 donkey anti-rabbit IgG anti-
body (Jackson ImmunoResearch, West Grove, PA) and avidin±
Texas Red (Perkin Elmer Life Sciences, Boston, MA). After
washing 3 times with PBS and 2 times with double-distilled
water, the specimens were mounted in glycerol solution (1:1
mixture with PBS) containing 1% propylgallate. To assess
uptake of FITC±dextran in vitro, the polysaccharide was
applied at 2±10 mg/ml for 12±16 h in culture.
Results
SIGN-R1 is expressed mainly in lymph nodes and spleen
In our previous report (23), the expression of SIGN-R1 was
detected by Northern blot analysis, which included RNA
samples from testis, kidney, skeletal muscle, liver, lung,
spleen, brain, heart, thymus, lymph nodes and intestine. The
Northern blot analysis showed highest expression of SIGN-R1
in lymph nodes, some expression in spleen, but little or no
expression in other tissues. In both lymph nodes and spleen,
the Northern blot revealed two major bands at 1.3 and 2.1 kb,
which would be expected to be generated from alternative use
of poly(A)+ signals in the 3¢-untranslated region of SIGN-R1
mRNA (26).
Rabbit polyclonal antibody against the C-terminal 13 amino
acid peptide of SIGN-R1 (23) was induced and puri®ed by
af®nity to the same SIGN-R1 peptide. The speci®city of this
Fig. 1. SIGN-R1 is expressed mainly in lymph nodes and spleen. (A) Speci®city of rabbit anti-mouse SIGN-R1 polyclonal antibody, con®rmed
by Western blot analyses on a series of closely related C-type lectin proteins. Fusion proteins of GFP and each C-type lectin domain of mouse
DC-SIGN, human DC-SIGN (the fusion protein contained both C-type lectin and neck domains, hence the higher mol. wt) and mouse SIGN-R1
were transiently expressed in 293T cells. Equivalent amounts of each cell lysate protein were analyzed by the Western blots detected with
anti-GFP antibody, anti-human DC-SIGN antibody and anti-mouse SIGN-R1 antibody respectively. (B) Western blot analyses of SIGN-R1 on
cell lysates from mouse lymph nodes, spleen, thymus, lung, heart and kidney. Signals corresponding to the monomer and complex forms of
SIGN-R1 are illustrated in two separate blots from SDS-PAGE gels of different densities, in order to provide better resolution. (C) Western blot
analyses of SIGN-R1 on cell lysates from lymph nodes, spleen, Peyer's patches and peritoneal exudate cells (PEC). Peritoneal exudate cells
were harvested 7 days after peritoneal injection of PBS, incomplete Freund's adjuvant (IFA) or complete Freund's adjuvant (CFA).
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antibody was assessed by Western blot analysis on the
closely related C-type lectins, human DC-SIGN and mouse
DC-SIGN, each expressed as a soluble GFP fusion protein
(Fig. 1A). Rabbit anti-SIGN-R1 antibody only bound to the C-
type lectin domain of mouse SIGN-R1, but not the homologous
lectin domains of human and mouse DC-SIGN. Although the
sequences of SIGN-R1 and DC-SIGN have considerable
similarity, even in the C-terminal 13 amino acids, the rabbit
anti-SIGNR-1 polyclonal appeared highly speci®c. The ex-
pressed SIGN-R1 GFP fusion proteins had a mol. wt appro-
priate for monomeric forms of the lectin (Fig. 1A).
Using this antibody, we examined the expression of SIGN-
R1 protein in various mouse tissues and cells by Western blot
analysis. SIGN-R1 protein was only detectable in lymph nodes
and spleen (Fig. 1B and 1C), as was the case for SIGN-R1
mRNA in these organs by Northern blot analysis. However,
SIGN-R1 protein was detected at very low levels or not at all in
B cells, T cells or CD11c+ DC isolated from lymph nodes and
spleen (data not shown), as expected from similar results of
previous RT-PCR experiments (23). Furthermore, SIGN-R1
protein was not detected in lysates from Peyer's patches or
peritoneal cells (comprised primarily of macrophages), the
latter with and without activation to form in¯ammatory
exudates (Fig. 1C). Similarly, SIGN-R1 protein was not found
in four macrophage cell lines: RAW264.7, IC-21, J774.1 and
P388D1 (data not shown). These Western blotting results
indicate strong reactivity in spleen and lymph node, but did
not reveal the reactive subset of macrophages that will
become apparent below.
SIGN-R1 forms monomer and multimer/complexes
We ®rst pursued the fact that SIGN-R1 protein by Western
blotting was heterogeneous relative to that expected for a 50-
kDa monomer. In lysates of lymph nodes, multiple forms were
noted, including a low-mol.-wt 50 kDa monomer and others of
higher mol. wt, 100 kDa or larger, presumptive multimers (Figs
1B and C, and 2B). In spleen, the 50-kDa monomeric form of
SIGN-R1 was absent but higher-mol.-wt species were evident
(Figs 1B and C, and 2B).
To further characterize these multiple forms of SIGN-R1
proteins, the full-length cDNA of SIGN-R1 was transiently
transfected into 293 cells, followed by lysis and Western
blotting on gradient gels (Fig. 2A). Without b-ME treatment,
most SIGN-R1 protein was in high-mol.-wt multimer/complex
forms, with less intense monomer and dimer bands. After the
b-ME treatment, the majority of SIGN-R1 protein migrated as a
monomer, but signi®cant amounts of presumed dimer, trimer
and tetramer forms remained. The formation of complex and
b-ME-resistant multimers in 293 cells was also observed in
CHO and RAW264.7 cells, transfected with SIGN-R1 and
SIGN-R1#48 cDNA (data not shown).
Unlike SIGN-R1 expressed in transfected cell-lines, most of
the multimer/complex forms of SIGN-R1 in spleen and lymph
nodes were resistant to b-ME treatment (Fig. 2B). The
Fig. 2. SIGN-R1 proteins can form multimers resistant to b-ME treatment. (A) Eukaryotic expression vectors containing no insert or SIGN-R1
cDNA were transfected into 293 cells and cell lysates were prepared 2 days later. Equivalent amounts of protein were boiled in sample buffers
without (±) or with (+) b-ME prior to Western blot analysis with rabbit anti-SIGN-R1 antibody. (B) Cell lysates were prepared from lymph nodes
and spleen. Equivalent amounts of lysate protein were boiled in sample buffer, ± or + b-ME prior to Western blot analysis with rabbit anti-
SIGN-R1 antibody. For improved resolutions, 4±15% gradient SDS±PAGE gels were used for the Western blots in (A) and (B).
Fig. 3. Antibodies to SIGN-R1 selectively label macrophages in splenic marginal zone, but not the red pulp (RP). SIGN-R1 is in green and
other cell-speci®c antibodies are in red, including: (A) MARCO scavenger receptor, (B) CD169 sialoadhesin [SER-4 antibody (28)], (C) B220
B cells, (D) CD11c DC particularly in the T cell areas (T) and in T cell transit regions (*) that interrupt the marginal zone (29), and (E) F4/80 red
pulp macrophages. (F) At a higher magni®cation, the marginal zone is comprised of SIGN-R1 macrophages and B cells.
Fig. 4. SIGN-R1+ macrophages (green) are restricted to the medulla of the lymph node. The second antibodies are listed on each panel and
identify: (A) B cell follicles overlying the T cell areas, (B and C) medullary macrophages labeling with the MARCO and F4/80 antibodies, and
(D) CD169+ [SER-4 antibody (28)] macrophages in the subcapsular sinus and medulla. (E) CD11c+ DC in the T cell regions (T) beneath the B
cell areas (B).
Fig. 5. Only a subset of released splenic phagocytes are SIGN-R1+. (A) FITC-labeled, iron-laden latex particles were given to mice i.v. 4 h
prior to isolating the phagocytes with a magnet and then labeled ex vivo with control rabbit antibody (red). (B) Same as (A), but labeled ex
vivo with rabbit anti-SIGN-R1. A subset of very large phagocytes labels for SIGN-R1, as shown as 3 examples.
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Fig. 3. (legend on facing page).
Fig. 4. (legend on facing page).
Fig. 5. (legend on facing page).
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monmeric form of SIGN-R1 protein only increased by a small
amount in lymph nodes after b-ME treatment. Interestingly,
there was no monomeric form of SIGN-R1 protein detectable
in spleen before and after b-ME treatment. Moreover, after b-
ME treatment, the Western blot signals for multimer/complex
forms of SIGN-R1 protein in spleen increased, possibly
because the b-ME treatment made epitopes for the SIGN-R1
antibody more accessible. As illustrated in the gradient gels in
Fig. 2, a large proportion of the complex forms of SIGN-R1
showed a mol. wt much larger than the expected 200-kDa for
tetramers. We interpret these results to mean that much of the
SIGN-R1 protein in spleen and lymph node is aggregated in a
manner that is largely resistant to dissociation with SDS and
b-ME.
Immunolabeling of SIGN-R1+ macrophages in tissue
sections of spleen and lymph node
To determine the cellular sites for SIGN-R1 expression, we
carried out immunolabeling studies on sections from spleen
and lymph node, the two organs where mRNA and protein
were detected. In spleen, rabbit anti-SIGN-R1 antibody
strongly labeled the large phagocytic cells in the marginal
zone that occupy much of the perimeter of each white pulp
nodule (Fig. 3, green color). In two-color studies, most of the
marginal zone macrophages also expressed MARCO, a
previously identi®ed (27) scavenger-type receptor (Fig. 3A).
In contrast, there was no staining for SIGN-R1 on macro-
phages termed marginal metallophils, labeled with SER-4 anti-
sialoadhesin (CD169) antibodies on the white pulp side of the
marginal zone (28) (Fig 3B). Likewise anti-SIGN-R1 did not
label B220+ B cells (Fig. 3C), CD11c+ DC found on the external
aspect of the marginal zone and in the T cell areas (29)
(Fig. 3D), and F4/80+ red pulp macrophages (30) (Fig. 3E).
Thus SIGN-R1 labels a subset of macrophages embedded
within the marginal zone of B cells (Fig. 3F), but none of the
other cellular elements of the spleen.
In lymph node, SIGN-R1 labeling was intense on macro-
phages found in the medullary region (Fig. 4A). These cells
also labeled for the MARCO and F4/80 macrophage antigens
(Fig. 4B and C). In contrast, the lymph node cortex did not
express SIGN-R1, including the rim of subcapsular sinus,
CD169+ macrophages (Fig. 4D). No labeling for SIGN-R1 was
found in the B cell areas or on CD11c+ DC in the T cell areas
(Fig. 4E). The large numbers of SIGN-R1+ medullary macro-
phages probably accounts for the fact that the most intense
signals in any organ in Northern and Western blots are found in
lymph node.
Isolation of SIGN-R1+ macrophages from spleen
We developed methods to release and enrich macrophages to
test if only a subset were SIGN-R1+ and eventually study their
properties further. Mice were injected i.v. with iron-containing
latex particles (either labeled with FITC or unlabeled). The
spleens were then subject to collagenase digestion and the
cell suspensions selected with a magnetic ®eld to provide a
population enriched in phagocytes corresponding to 0.2% of
the total cell suspension. The isolated cells were highly
enriched in latex-laden phagocytes and ~5% of the phago-
cytes were distinct, large, `¯ower or petal-shaped' cells
labeling strongly for SIGN-R1 (Fig. 5). These cells occasionally
contained two or three nuclei (data not shown).
Selective uptake of dextrans by SIGN-R1+ macrophages
in vivo and in vitro
To verify that the marginal zone macrophages marked by
SIGN-R1 would take up polysaccharides, we administered
polysaccharides at a dose of 100 mg/mouse i.v. The SIGN-R1+
cells were the major site for binding of 2000- and 70-kDa forms
of anionic FITC±dextran (Fig. 6A). These polysaccharides
were present in the marginal zone for 1±20 h and then
disappeared over the subsequent day (Fig. 6A). In addition to
the marginal zone, FITC±dextran was found in a web in the B
cell area (white arrows, Fig. 6A), up to the 48 h that we followed
their persistence. Dextran presumably activated the alterna-
tive complement pathway in the mice and were then
recognized by CD21 complement receptors on follicular DC
in the B cell areas. Small amounts of FITC±dextran also were
noted in presumptive DC in the T cell areas (not shown). When
we compared the splenic localization of FITC±dextran with
FITC±latex following i.v. injection, the FITC-latex was found in
both marginal zone and red pulp, and did not localize to the B
cell follicles (not shown).
To phenotype the cells internalizing FITC±dextran, two-color
immuno¯uorescence studies were performed (Fig. 6B). The
FITC±dextran-bearing cells expressed the marginal zone
macrophage antigens, ERTR9 and SIGN-R1 (Fig. 6B, left
panels), but little or no CD11c (DC), B220 (B cells), SER4/
CD169 (marginal zone metallophils) or F4/80 (red pulp
macrophages) (Fig 6B).
In vitro experiments were carried out to ensure that FITC±
dextran would have access to SIGN-R1+ and SIGN-R1±
phagocytes, isolated as in Fig. 5. When the phagocytes
were exposed to 10 mg/ml FITC±dextran, only the SIGN-R1+
phagocytes took up the polysaccharide (Fig. 6C). Therefore
SIGN-R1+ macrophages are the principal phagocytes in-
volved in the splenic uptake of dextrans.
SIGN-R1 mediates endocytic uptake of polysaccharide in
culture and in vivo
To determine if SIGN-R1 could itself mediate dextran uptake,
the cDNA was transfected into three different cell lines (293
human renal epithelium, CHO and the RAW267.4 macrophage
cell line). The transfected cells became reactive with SIGN-R1
antibody as well as the previously described ER-TR9 antibody,
a reagent that selectively stains marginal zone macrophages
(6) and blocks uptake of dextran in vivo (7). Using the FACS to
monitor the uptake of FITC±dextran at the single-cell level, we
found that SIGN-R1 transfectants acquired the capacity to
take up FITC±dextran at low doses (10 mg/ml, Fig. 7A). By
deconvolution microscopy, SIGN-R1 transfected cells [iden-
ti®ed in blue with either monoclonal ER-TR9 (not shown) or
polyclonal SIGN-R1 (Fig. 7B)] internalized dextran into numer-
ous endocytic vesicles. At 37°C, the FITC±dextran containing
intracellular compartments showed little or no double labeling
with antibodies to either LAMP-1/CD107a, which labeled
abundant lysosomes in these cells, or with antibody to the
transferrin receptor, which labeled abundant endosomes
(Fig. 7B). Using either microscopic or FACS assays, cells
transfected with the vector control did not internalize above
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Fig. 6. Uptake of FITC±dextran into SIGN-R1+ macrophages. (A) Uptake in vivo monitored 1, 24 and 48 h after injection of 100 mg/mouse of
anionic 2000-kDa FITC±dextran. The FITC (left) and SIGN-R1 (lavender, middle) labels are in similar cells in the single-color micrographs,
resulting in a light blue color in the overlay micrograph (right panels). Retention of dextran in the B cell follicles (white arrows) was apparent for
longer periods than retention within marginal zone macrophages. (B) Only macrophages in the marginal zone take up FITC±dextran (green).
These phagocytes express high levels of SIGN-R1, but little or no F4/80 and CD169 antigen, found on red pulp and marginal metallophil
macrophages respectively. CD11c+ DC and B220+ B cells also show little or no uptake of FITC±dextran. (C) Selective uptake of FITC±dextran
by isolated marginal zone. SIGN-R1+ macrophages (red) cultured overnight in 10 mg/ml FITC±dextran.
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Fig. 7. SIGN-R1 mediates the uptake of FITC±dextran. (A) FACS staining of 293 cells without or with transfection of SIGN-R1, and exposed to
0 or 10 mg/ml FITC±dextran for 2 h at 4 and 37°C. In data that are not shown, the SIGN-R1 transfectants acquired reactivity to ER-TR9 mAb.
(B) Stably transfected RAW264.7 SIGN-R1 transfectants were mixed with an excess of non-transfected RAW264.7 cells and cultured in 10 mg/
ml FITC±dextran (green) for 2 h followed by double labeling with rabbit anti-SIGN-R1 antibody (lavender) and either rat anti-LAMP-1 (top) or
anti-transferrin receptor (bottom) in red. (C) Single examples of splenic macrophages cultured for 12 h in 2 mg/ml FITC±dextran and either
10 mg/ml control rat Ig (left) or 10 mg/ml of blocking ER-TR9 antibody (right). (D) Blocking of uptake of 100 mg of 2000-kDa FITC±dextran into
splenic marginal zone macrophages in vivo. FITC±dextran was administered i.v. for 1 h in mice pretreated 30 min earlier with 25 mg of control
Ig (top row), ER-TR9 rat anti-SIGN-R1 mAb (middle row) or rabbit anti-SIGN-R1 polyclonal antibody (lower row).
184 SIGN-R1 dextran receptor on marginal zone macrophages
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on July 15, 2014
http://intim
m
.oxfordjournals.org/
D
ow
nloaded from
 
the background seen with SIGN-R1± cells and no uptake was
seen if the SIGN-R1 transfectants were exposed to poly-
saccharide at 4°C (not shown).
To evaluate the function of SIGN-R1 on primary populations
of macrophages, we performed blocking studies with anti-
SIGN-R1 antibodies. Rat ER-TR9 mAb at 10 mg/ml blocked
FITC±dextran uptake by isolated splenic macrophages
(Fig. 7C). Both rat and rabbit anti-SIGN-R1 antibodies, given
at a dose of 25 mg per mouse, blocked the uptake of i.v. FITC±
dextran by marginal zone macrophages in spleen sections
(Fig. 7D). No blocking was observed with non-reactive control
antibody (Fig. 7D top row) or if anti-SIGN-R1 was used to try to
block FITC±latex uptake in culture (not shown). Therefore
SIGN-R1 is able to mediate the uptake of polysaccharides, as
is characteristic of marginal zone macrophages in vivo and
in vitro.
Discussion
The new family of C-type lectins, termed SIGN-R1, 2, 3 and 4
(23), is so named because of homology to a lectin termed DC-
SIGN that is expressed by DC. However, the SIGN-R them-
selves are not clearly expressed by DC. Instead, we now ®nd
that SIGN-R1 is primarily found on subsets of macrophages in
splenic marginal zone and lymph node medulla. In spleen cell
suspensions, these macrophages represent ~0.01% of the
cells that can be released by current methods. SIGN-R1 is the
target for the previously described antibody ER-TR9 (6,7) and,
importantly, this lectin on a minor fraction of spleen cells
serves as the major endocytic receptor for dextrans. Our
®ndings have one difference from a conclusion in the prior
literature, i.e. that neutral polysaccharides are selectively
captured by marginal zone macrophages (7±10). With the
reagents that we studied, we observed clearance by SIGN-
R1+ macrophages of both anionic and neutral forms of
dextran, and with a wide variety of mol. wt, 70±2000 kDa.
The ef®cient uptake of these dextrans could be replicated
when cell lines from three different species and tissues (293
human renal epithelium, CHO and RAW267.4 mouse macro-
phages) were transfected with SIGN-R1.
Dextrans are often used to study endocytosis by DC, which
express little or no SIGN-R1. However, it is possible that DC
use other receptors like the macrophage mannose receptor
and/or that much higher concentrations of dextrans (~1 mg/
ml) are needed to observe strong dextran uptake in DC (31).
While SIGN-R1 protein is readily identi®ed in lysates of
spleen and lymph node, little of it exists as a simple monomer.
Instead, the lectin migrates as a complex in SDS±PAGE, most
likely multimers or larger complexes. Such complexes could
originate following binding of SIGN-R1 to large complex
carbohydrates in tissues, which are somehow stable in SDS
and b-ME treatment. The molecular basis and signi®cance of
the dominant high-mol.-wt SIGN-R1 forms are currently
unclear. One possibility is that the aggregation of SIGN-R1
enhances the binding and/or uptake of polysaccharides.
In the case of HIV-1 uptake via the homologous DC-SIGN
lectin, the virus can be sequestered for days in non-lysosomal
compartments (16,32) and then the HIV-1 is transferred in an
infectious state to other T cells. Perhaps this sort of traf®c into
and out of the cell occurs with SIGN-R1 ligands in macro-
phages. At this point, it is evident that uptake via SIGN-R1
primarily delivers dextrans to intracellular compartments
lacking in the LAMP-1 lysosomal and transferrin receptor
endosomal markers. These ®ndings parallel the observations
on HIV-1 uptake via DC-SIGN, but the fate of polysaccharides
internalized via SIGN-R1 needs to be pursued.
Although macrophages are a major cellular component of
the spleen, it is dif®cult to liberate these cells into suspension,
and then separate them from most of the lymphocytes and DC.
To be able to study splenic macrophages in isolation, we have
developed a method that enriches the cells on the basis of
substantial particle uptake in vivo. DC primarily take up only 1±
2 latex particles per cell (33), but when we administer iron-
laden latex particles to mice i.v. and then dissociate the
spleens in collagenase 4 h later, we are able to use magnets to
isolate phagocytes with >3 particles/cell and to >90% purity.
These phagocyte populations lack CD11c+ DC, but do contain
a subset (~5%) of very large `petal'-shaped cells that stain
strongly with monoclonal and polyclonal anti-SIGN-R1 anti-
bodies. These macrophages selectively internalize FITC±
dextran at low doses and the uptake is blocked by ER-TR9
mAb to SIGN-R1. Such results are valuable since events other
than receptor expression may in¯uence the in vivo distribution
and uptake of macromolecules. Our results with macrophages
in vivo and in vitro indicate that phagocytes ignore low
concentrations of dextrans unless they express the newly
de®ned SIGN-R1 receptor for these polysaccharides. SIGN-
R1 may be an important mediator for the uptake of microbes in
both spleen and lymph node, particularly through the recog-
nition of microbial polysaccharides.
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